Internal Medicine, Medical Oncology · Los Angeles, CA
NPI
1184788432
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1441 Eastlake Ave, Nor 8302e
Los Angeles, CA, 90089
Phone (323) 865-3105
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
656 services
Medicare patients, 2024
160
Average age 74
Drug cost, 2024
$2.9M
454 prescriptions
Company payments, 2025
$140K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen Liu was code 99215 (office e&m - established), 414 times for 117 patients. In total Stephen Liu billed 656 services in 9 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 414 | 117 | $127.96 | $53K |
| 99215 Office E&M - Established | Office | 57 | 27 | $171.66 | $9,785 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 51 | 34 | $15.23 | $777 |
| 99214 Office E&M - Established | Facility | 34 | 28 | $87.71 | $2,982 |
| 99205 Office E&M - New | Facility | 31 | 31 | $156.99 | $4,867 |
By year: 2022 $59K for 529 services; 2023 $49K for 435 services; 2024 $78K for 656 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen Liu prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 101 prescriptions and refills. In total Stephen Liu wrote 454 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 101 | 111 | 14 | $1.8M |
| Hydrocortisone Generic | 26 | 26 | Under 11 | $669 |
| Ondansetron Hcl Generic | 19 | 19 | 13 | $136 |
| Eliquis Apixaban | 18 | 22 | Under 11 | $12K |
| Xarelto Rivaroxaban | 16 | 25 | Under 11 | $14K |
| Gavreto Pralsetinib | 16 | 16 | Under 11 | $192K |
| Oxycodone Hcl Generic | 15 | 15 | 11 | $278 |
| Prednisone Generic | 14 | 14 | Under 11 | $55.29 |
| Zolpidem Tartrate Generic | 14 | 14 | Under 11 | $42.44 |
| Xalkori Crizotinib | 12 | 12 | Under 11 | $275K |
| Lumakras Sotorasib | 12 | 12 | Under 11 | $257K |
Brand drugs: 204 claims; generic drugs: 250 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen Liu $140K ($132K in general payments such as food, travel and fees and $8,784 for research) from 27 companies. The largest payer was Jazz Pharmaceuticals Inc. with $50K.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 36 | $50K |
| AstraZeneca Pharmaceuticals LP AZN | 16 | $21K |
| Hoffmann-La Roche Limited ROG.SW | 9 | $18K |
| F. Hoffmann-La Roche AG ROG.SW | 6 | $8,778 |
| GlaxoSmithKline, LLC. GSK | 2 | $6,600 |
| AstraZeneca UK Limited AZN | 2 | $5,072 |
| Genentech USA, Inc. ROG.SW | 4 | $4,953 |
| Amgen Inc. AMGN | 3 | $4,196 |
| Gilead Sciences, Inc. GILD | 3 | $3,990 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $3,605 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.